News

The first and only atopic dermatitis conference, Revolutionizing Atopic Dermatitis (RAD), will be hosting its third event, in a virtual format.

This week’s edition of The Mainstream Patient features stories about castor oil, Botox for migraines, apple cider vinegar baths, formaldehyde in beauty products, plus more.

Ivermectin 0.5% lotion (Sklice, Arbor Pharmaceuticals) is now approved by the U.S. Food and Drug Administration (FDA) for nonprescription use to treat head lice.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of the content featured this week includes a new episode of our podcast focusing on telemedicine use in dermatology, female representation within the dermatological surgery space, pulsed dye laser and botulinumtoxinA as a combination treatment for rosacea, plus more.

Promising outcomes are being reported from clinical trials investigating Nano-Pulse Stimulation technology to treat nodular basal cell carcinoma and cutaneous, non-genital warts.

Michael Sherling, M.D., practicing dermatologist and chief medical and strategy officer at Modernizing Medicine, discusses the recent rise in telemedicine use in dermatology, the benefits and detriments, as well as the future for the industry.

This week’s edition of The Mainstream Patient features stories about postpartum hair loss, vitamin C benefits, witch hazel, fraxel laser treatments, isotretinoin’s effect on both the skin and mind, oily skin myths, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of the content featured this week includes new 730 nm picosecond laser for benign pigmented lesions, managing patient volumes during the COVID-19 pandemic, tips on how to build your brand as a physician, plus more.

Since the start of the pandemic, dermatologists have seen an average 50% drop in patient volume. While teledermatology has offered a channel for non-urgent patients and patient visits are rebounding, overall patient volumes are still significantly lower than 2019.

In the final installment of this video series, Paige Velasquez Budde, CEO of Zilker Media, provides some useful tips for jump starting your brand as a physician.

In this month’s Legal Eagle article, David J. Goldberg, M.D., J.D., discusses the different professional standards of disclosure that a physician must fulfill when treating patients.

In part two of this video series, Paige Velasquez Budde, CEO of Zilker Media, reveals the benefits of shaping your brand awareness.

Catch up on all of the latest news coming out of the 2020 American Society for Dermatologic Surgery (ASDS) virtual meeting.

In this video interview, Paige Velasquez Budde, CEO of Zilker Media, explains the importance of building and shaping your brand as a physician.

This week’s edition of The Mainstream Patient features stories about a new toxic-free cosmetics bill in California, the benefits of benzoyl peroxide for acne, the legitimacy of collagen supplements, potential sunscreen changes by the FDA, plus more.

A glimpse at what to expect from Dermatology Times this week.

Dr. Jack Levy, chief resident in the Department of Dermatology at Emory University, discusses his recent presentation at the 2020 ASDS meeting about using high frequency ultrasound to distinguish scar tissue from neoplasm.

ICYMI, some of the content featured this week includes articles about abobotulinumtoxinA injections for oily forehead, promising therapies for blastic plasmacytoid dendritic cell neoplasm (BPDCN), the benefits of CBD for the skin, plus more.

Dr. Katarina Kesty, St. Petersburg Skin and Laser, St. Petersburg, Fla., discusses her presentation at the 2020 virtual American Society for Dermatologic Surgery (ASDS) meeting about her research using abobotulinumtoxinA injections to combat oil on the forehead.

The use of CBD skincare products is recently on the rise, but do these products really possess the skin benefits companies claim they do?

Media expert Paige Velasquez Budde, CEO of Zilker Media, explains the importance of building a brand as a physician, as well as some mistakes to avoid and tips on how to grow and shape your brand.

Entrepix Medical, LLC, launches their new Planatome blade, which has shown in multiple studies to increase wound closure, reduce tissue trauma and strength the wound.

Aesthetic medicine company, Allergan Aesthetics, launches a new brand identity focused on empowering confidence and promoting diversity.

This week’s edition of The Mainstream Patient features stories about snail slime in skincare, how to treat hyperpigmentation, different exfoliation methods, maskne during the fall, plus more.

ICYMI, some of the content featured this week includes articles about antihistamines for alopecia areata, treating pediatric patients with skin of color, topical roflumilast study results, racial disparities in melanoma survival, plus more.

The U.S. FDA has approved to expand the indication for golimumab (SIMPONI ARIA, Janssen Pharmaceutical Companies of Johnson & Johnson) to include it was a treatment for active psoriatic arthritis (PsA) in pediatric patients 2 years and older.